TechnologiesCloudIndustriesHealthcare & Life Sciences

Optimism and Opportunity in Life Sciences: Thinking back and looking forward

“A pessimist sees difficulty in every opportunity. An optimist sees opportunity in every difficulty.” — Winston Churchill

Never have those words rung as true as today. Constant, ever-accelerating change has become the new normal in every walk of life. For Life Sciences companies, significant changes are impacting every level of business, from the marketplace to digital technology to regulatory requirements to uncertain political environments.

Just over one year ago, change arrived in the Life Sciences content management vendor landscape from an unexpected source: the acquisition of Dell EMC’s Enterprise Content Division by OpenText. Uncertainty swirled last January as customers and partners tried to understand what was in store for their current investments and competitors fanned the flames of doubt.

Has the past year been one of opportunity or difficulty? Recently, we hosted a webcast that provided a “one year in” perspective on all things Documentum. You can watch the recording here. I think the speakers all agree that we’ve come a long way. From my vantage point focusing on life sciences, I say it’s been a year of opportunity! Read on and see why.

An unshakable commitment in world that is transforming

Last week, we introduced OpenText Life Sciences Express. Designed as an extension to OpenText Documentum for Life Sciences, this lightweight application provides an intuitive, role-based user experience for managing content and tasks anywhere, anytime, on any device without compromising security or compliance. This blog and video explain the benefits of combining an intuitive, tailored user experience, cloud accessibility, and GxP-compliant life sciences solutions.

Not only does Life Sciences Express help boost the productivity of your employees and external partners, but it also showcases the OpenText commitment to developing next-generation, cloud-native content applications based on the OpenText cloud services platform.

While this release is recent, it’s just one proof point supporting the OpenText promise to support and invest in Life Sciences, respond to customers’ needs, and help them boost productivity. Here are some other highlights since the acquisition in January 2017:

  • Last March, we introduced OpenText Documentum for Life Sciences 4.3, with an enhanced user experience and a Java-free client requiring no client-side installation.
  • In September, we launched a beta program that provided hands-on access to OpenText Life Sciences Express.
  • In November, Documentum for Life Sciences solutions were integrated with OpenText Information Hub (iHub) from the OpenText analytics portfolio, delivering visual reporting for actionable insight to speed decision making.

To me, this was a great example of leveraging the OpenText product portfolio to deliver greater value to our life sciences customers. This article features a few screenshots of the regulatory dashboard.

Proactive communication and assurance from OpenText leadership

From the start, the OpenText leadership team communicated their vision of combining the strengths of Documentum and OpenText to build life sciences solutions that would set new industry benchmarks. Shortly after the acquisition was official, OpenText executives personally called and visited Documentum customers to understand their concerns, separate fact from fiction, and offer their assurances. They also discussed the synergies that our customers could use to their advantage.

The message was abundantly clear, “OpenText will protect Documentum Customers’ investments with innovation and continued full support for both Documentum and OpenText Content Suite.”

This outreach included Life Sciences user group meetings in key cities during Innovation Tour, and the creation of a Product Advisory Council for Documentum Life Sciences customers to provide feedback and aid product direction.

Demos, discussions, and roadmaps bring it all together at Enterprise World

Just six months after the acquisition, OpenText hosted customers old and new at Enterprise World. Our life sciences customers had a dedicated track where our subject matter experts, customers, and executives could share information, discuss challenges and opportunities, and learn about our strategy and roadmap. Demos were presented, meetings were held, and customers left with a clear understanding of the future.

These efforts produced clear results. The feedback was positive and customers responded. For example, one company recommitted to OpenText and expanded its integration of OpenText Documentum for Life Sciences to multiple plants and thousands of users around the world–proving that commitment leads to commitment.

The future is bright…

The past year has been marked by change for many of us in life sciences. Challenges and opportunities are everywhere but, from my vantage point, the opportunities far outweigh the challenges. OpenText is delivering on its promise to support and invest in life sciences solutions. In turn, that commitment is helping our customers as they continue to innovate and deliver on their own promises: developing products that create a healthier world.

Together, we will continue to strive for excellence and innovation as we embrace the opportunities that change always brings.

Lori McKellar

Lori McKellar is the Senior Director of Product Marketing for OpenText. She focuses on products, solutions and services related to AI, Analytics, Low-code development and Process Automation, that help organizations increase automation, operational efficiencies and maximize revenue. She brings over twenty years’ experience in selling and marketing enterprise software in information management.

Related Posts

Back to top button